ASLAN Pharma (NASDAQ:ASLN) just reported results for the fourth quarter of 2023.
- ASLAN Pharma reported earnings per share of -78 cents. This was below the analyst estimate for EPS of -65 cents.
- The company did not report any revenue for the quarter.
Source: iQoncept / Shutterstock
ASLAN Pharma (NASDAQ:ASLN) just reported results for the fourth quarter of 2023.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/04/asln-stock-earnings-aslan-pharma-for-q4-of-2023/.
©2025 InvestorPlace Media, LLC